Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease

Lipids in Health and Disease

Volumn 7, Issue , 2008, Pages

  Bahri, Raoudha ^a   Esteban, Esther ^b   Moral, Pedro ^b   Hassine, Mohsen ^a   Hamda, Khaldoun Ben ^c   Chaabani, Hassen ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF BARCELONA   (Spain)

^c FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; ALLELE; APO CI GENE; APO CII GENE; ARTICLE; BLOOD DONOR; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ANALYSIS; GENETIC MARKER; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; POPULATION; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TUNISIA; AGED; BLOOD; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; MIDDLE AGED; NEGRO;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES; TUNISIA;

EID: 58149389414     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-7-46     Document Type: Article

References (45)

1. A prospective study of cholesterol, apolipoproteins and the risk of Myocardial infarction. MJ Stampfer FM Sacks S Salvini WC Willett CH Hennekens, N Engl J Med 1991 325 373 381 2062328
2. Genetic environmental effects on coronary heart disease risk factors in northern Norway. The cardiovascular disease study in Finn mark. T Brenn, Ann Hum Genet 1994 58 369 379 10.1111/j.1469-1809.1994.tb00733.x 7864592
3. Human plasma lipoprotein (a): Structural properties. JW Gaubatz C Heideman AM Gotto JD Morrisett GH Dahlen, J Biol Chem 1983 258 4582 4589 6220008
4. Molecular definition of the extern size polymorphism in apolipoprotein (a). C Lackner JC Cohen H Hobbs, Hum Mol Genet 1993 2 933 940 10.1093/hmg/2.7.933 8395942
5. 5' control regions of the apolipoprotein (a) gene and members of the related plasminogen gene family. DP Wade JG Clarke GE Lindahl AC Liu BR Azysow K Meer K Schwartz RM Lawn, Proc Natl Acad Sci USA 1993 90 1969 1973 10.1073/pnas.90.4.1369
6. A pentanucleotide repeat polymorphism in the 5'-control region of the apolipoprotein (a) gene is associated with lipoprotein (a) plasma concentrations in Caucasians. M Trommsdorff S Köchl A Lingenhel F Kronenberg R Delport H Vermaak L Lemming IC Klausen O Faergeman G Utermann HG Kraft, J Clin Invest 1995 96 150 157 7615785 10.1172/JCI118015
7. Apolipoprotein (a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease. H Amemiya T Arinami S Kikuchi K Yamakawa-Kobayashi L Li H Fujiwara M Hiroe F Marumo H Hamaguchi, Atherosclerosis 1996 123 181 191 10.1016/0021-9150(96)05806- 6 8782849
8. Comparative analysis of apo (a) gene alleles Distribution of pentanucleotide repeats in position -1373 and C/T transition in position (+93) among patients with myocardial infarction and a control group in St Petersburg, Russia. MV Volkova VI Vasina EV Fomicheva EI Shwartz, Biochem Mol Med 1997 61 208 213 10.1006/bmme.1997.2582 9259986
9. Apolipoprotein E: Far more than a lipid transport protein. RW Mahley SC Rall, Annu Rev Genomics Hum Genet 2000 1 507 537 10.1146/annurev.genom.1.1.507 11701639
10. Apolipoprotein E genotype and plasma levels in coronary artery disease: A case-control study in the Italian population. RM Corbo T Vilardo M Ruggeri AT Gemma R Scacchi, Clin Biochem 1999 32 217 222 10.1016/S0009-9120(99)00011-9 10383084
11. Cholesterol Ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population. T Isbir H Yilmaz B Agachan ZE Karaali, Clin Genet 2003 64 228 234 10.1034/j.1399-0004.2003.00137.x 12919138
12. Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction. WM Nillesen HJM Smeets OBA Van, Nucleic Acids Res 1990 18 3428 1972565 10.1093/nar/18.11.3428-a
13. An AvaII polymorphism in the human apolipoprotein CII. J Geisel C Weibhaar K Oette, Clin Genet 1996 49 163 8737984
14. A common HpaI/RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. Y Xu L Berglund R Ramakrishnan R Mayeux C Ngai S Holleran B Tycko T Leff S Schachter, J Lipid Res 1999 40 50 58 9869649
15. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk. C Wang X Zhou S Ye D Han X Tan F Zheng Q Shi, Int J Hyg Environ Health 2006 209 265 273 10.1016/j.ijheh.2005.12. 005 16459141
16. Apolipoprotein E-CI-CII gene cluster and its effect on serum lipid levels. CH Whang X Zhou Q Shi F Zheng, Wei Sheng Yan Jiu 2005 34 104 108 15862040
17. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. WT Friedewald RI Levy DS Fredrickson, Clin Chem 1972 18 499 502 4337382
18. Apolipoprotein E: risk factor for Alzheimer disease. MS Tsai EG Tangalos RC Petersen GE Smith DJ Schaid E Kokmen RJ Ivnik SN Thibodeau, Am J Hum Genet 1994 54 643 649 8128961
19. Arlequin: software for population genetics data analysis. S Schneider D Roessli L Excoffier, Ver. 2.0 Geneva, Switzerland: Genetics and Biometry Laboratory, Department of Anthropology and Ecology, University of Geneva 2000
20. New insights into the genetic history of Tunisians: Data from Alu insertion and apolipoprotein E gene polymorphisms. R Bahri E Esteban P Moral H Chaabani, Ann Hum Biol 2008 35 22 33 10.1080/03014460701753729 18274923
21. Factors de risc genetics per a la Cardiopatia isquèmica Polimorfismes en genes del metabolisme lipoproteic. N Valveny, PhD thesis University of Barcelona, Barcelona 2000
22. Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T (+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians. K Valenti E Aveynier S Leauté F Laporte AJ Hadjian, Atherosclerosis 1999 147 17 24 10.1016/S0021-9150(99)00137-9 10525120
23. Apo(a) Variants and Lipoprotein(a) in Men with or without Myocardial infarction. G Chimienti BL Lamanuzzi M Nardulli AM Colacicco, Exp Mol Pathol 2002 73 28 34 10.1006/exmp.2002.2445 12127051
24. A pentanucleotide repeat polymorphism (TTTTA) in the apolipoprotein (a) gene-Its distribution and its association with the risk of cardiovascular disease. CM Calo L Varesi M Memmi P Moral G Vona, Coll Antropol 2003 27 1 105 115 12974138
25. Apolipoprotein molecular variation in Moroccan Berbers: pentanucleotide (TTTTA) n repeat in the LPA gene and APOE-C1-C2 gene cluster. N Harich E Esteban A Lopez-Alomar A Chafik P Moral, Clin Genet 2002 62 240 244 10.1034/j.1399-0004.2002.620310.x 12220441
26. GM polymorphisms and the evolutionary history of modern humans. H Chaabani, Annales de génétique 2002 45 197 206 10.1016/S0003-3995(02)01140-1
27. Study of GM Immunoglobulin Allotypic System in Berbers and Arabs from Morocco. C Coudray E Guitard M Kandil N Harich M Melhaoui A Baali A Seven P Moral JM Dugoujon, Am J Hum Biol 2006 18 23 34 10.1002/ajhb.20465 16378347
28. Molecular variation at genes and the history of human populations-Data on candidate genes for cardiovascular risk in the Mediterranean. P Moral N Valveny A Lopez-Alomar C Calo M Kandil N Harich E Gonzalez-Perez M Via E Esteban JM Dugoujon G Vona, Coll Antropol 2003 27 2 523 536 14746139
29. Lipid abnormalities in Greek patients with coronary artery disease. MS Elisaf KC Siamopoulos TJ Tselegarides ETh Bairaktari JA Goudevenos AD Tselepis OE Tsolas DA Sideris, Int J Card 1997 59 177 184 10.1016/S0167-5273(96)02916-6
30. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. MG Baroni A Berni S Romeo M Arca T Tesorio G Sorropago U Di Mario DJ Galton, BMC Med Genet 2003 4 8 12964943 10.1186/1471-2350-4-8
31. Homocysteine level and coronary artery disease. MB Kazemi K Eshraghian GR Omrani KB Lankarani E Hosseini, Angiology 2006 57 9 14 10.1177/ 000331970605700102 16444451
32. Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort. G Vrentzos JA Papadakis N Malliaraki EA Zacharis K Katsogridakis AN Margioris PE Vardas ES Ganotakis, Angiology 2004 55 517 524 10.1177/000331970405500507 15378114
33. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. SS Kang EL Passen N Ruggie PW Wong H Sora, Circulation 1993 88 1463 1469 8403293
34. Sequence polymorphisms in the apolipoprotein (a) gene and their association with lipoprotein (a) level and myocardial infarction. The ECTIM Study. L Brazier L Tiret G Luc D Arvelier JB Ruidavets A Evans J Chapman F Cambien J Thillet, Atherosclerosis 1999 144 323 333 10.1016/S0021-9150(98)00333- 5 10407493
35. Single effects of apolipoprotein B, (a) and E polymorphisms and interaction between plasminogen activator inhibitor-1 and apolipoprotein (a) genotypes and the risk of coronary artery disease in Czech male Caucasians. P Benes J Muzik J Benedik M Frelich L Elbl A Vasku V Znojil J Vacha, Mol Genet Metab 2000 69 137 143 10.1006/mgme.1999.2957 10720441
36. The association of serum lipoprotein (a) levels, apolipoprotein(a) size and (TTTTA)n polymorphism with coronary heart disease. A Kalina A Csaszar G Füst B Nagy C Szalai I Karadi J Duba Z Prohaszka L Horvath H Dieplinger, Clin Chim Acta 2001 309 45 51 10.1016/S0009-8981(01)00500-9 11408005
37. Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran. H Kharrazi RA Vaisi AR Sabokroh T Pourmotabbed, Clin Biochem 2006 39 613 616 10.1016/j.clinbiochem.2006.02.002 16545358
38. Associations of apolipoprotein E polymorphism with low-density lipoprotein size and subfraction profiles in arab patients with coronary artery disease. AO Akanji CG Suresh HR Fatania R Al-Radwan M Zubaid, Metabolism 2007 56 484 490 10.1016/j.metabol.2006.11.006 17379005
39. Contemporaneous carrier-state of two or three " proatherosclerotic" variants of APOE, ICAM1, PPARA and PAI-1 genes differentiate CAD patients from healthy individuals. I Zak A Balcerzyk B Sarecka P Niemiec Z Ciemniewski S Dylag, Clin Chim Acta 2005 362 110 118 10.1016/j.cccn.2005.06.011 16043164
40. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. S Lehtinen T Lehtimäki T Sisto JP Salenius M Nikkilä J Hannu T Koivula F Ebeling C Ehnholm, Atherosclerosis 1995 114 83 91 10.1016/0021-9150(94)05469- Y 7605379
41. Association of apolipoprotein E phenotype with plasma lipoproteins in African -American and white young adults. BV Howard SS Gidding K Liu, Am J Epidemiol 1998 148 859 868 9801016
42. In vivo metabolism of apolipoproteins AI and E in patients with abetalipoproteinemia: implications for the roles of apolipoprotein B and E in HDL metabolism. K Ikewaki DJ Rader LA Zech JrHB Brewer, J Lip Res 1994 35 1809 1819
43. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. LJ Martin PW Connelly D Nancoo N Wood ZJ Zhang G Mapire E Quinet AR Tall Y Marcel R Mc Pherson, J Lipid Res 1993 34 3 437 446 8468527
44. Effects of different exercise training intensities on lipoprotein cholesterol fractions in healthy middle aged men. RA Stein DW Michielli MD Glantz H Sardy A Cohen N Goldberg CD Brown, Am Heart J 1990 119 277 283 10.1016/S0002-8703(05)80017-1 2301216
45. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. ESER De Oliveira D Foster M McGee Harper CE Seidman JD Smith JL Breslow EA Brinton, Circulation 2000 102 2347 2352 11067787